To further validate the hypothesis that CXCL13+ T cells are tumor‐reactive, we scored T cells for tumor‐reactive markers and found that CXCL13+ T cells exhibited significantly higher reactivity compared to CXCL13− T cells (Figure 5I). This evidence concerns the gene CXCL13 and neoplasm.